AFYA II (CAHS TRANSFER)
The Afya II is randomized comparative controlled trial – funded by the University of California Berkeley – implemented by MDH in collaboration with Health for a Prosperous Nation (HPON-TZ) in Shinyanga, Tanzania. The study aims at optimizing the efficiency and implementation of cash transfers to improve ART adherence among PLHIVs. This study will evaluate the dose-response relationship between cash transfers and viral suppression and identify the most effective cash transfer size for maximal retention and viral suppression outcomes after 6 months of ART use. By the end of 2018 study enrollment was complete and follow-up ongoing.